Deutsches Herzzentrum Muenchen: Myocardial Infarction trials
The registry lists 13 Myocardial Infarction studies with Deutsches Herzzentrum Muenchen as lead sponsor. 0 are open to participants now and 0 have results posted.
Phase 3 1Phase 4 6No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Prospective, Randomized Trial of BVS Veruss EES in Patients Undergoing Coronary Stenting for Myocardial InfarctionStatus unknownNCT01942070Not applicable
- Efficacy Study of Combined Prasugrel and Bivalirudin Versus Clopidogrel and Heparin in Myocardial InfarctionStatus unknownNCT00976092Phase 4
- Beyond 12 Hours Reperfusion AlternatiVe Evaluation TrialCompletedNCT00759629Phase 4
- Efficacy Study of LV Assist Device to Treat Patients With Cardiogenic Shock (ISAR-SHOCK)CompletedNCT00417378Phase 4
- Efficacy Study of Erythropoietin After Revascularization in Myocardial Infarction (REVIVAL-3)CompletedNCT00390832Phase 3
- Randomized Comparison of Abciximab Plus Heparin With Bivalirudin in Acute Coronary SyndromeCompletedNCT00373451Phase 4
- Innovative Stratification of Arrhythmic Risk (ISAR-Trial): ElderyCompletedNCT00196300
- Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Female PatientsCompletedNCT00196287
- Autonomic Regulation Trial (ART)CompletedNCT00196274
- Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Long-Term PredictionCompletedNCT00196261
- Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Diabetes MellitusCompletedNCT00196235
- Value of Abciximab in Patients With AMI Undergoing Primary PCI After Clopidogrel Pretreatment (BRAVE 3)CompletedNCT00133250Phase 4
- Bone Marrow Stem Cell Mobilisation Therapy for Acute Myocardial Infarction (AMI)(REVIVAL-2)CompletedNCT00126100Phase 4